Silo Pharma, Inc.
Close on Oct 19, 2026
- Market cap
- $1.24M
- P/E (TTM)
- –
- Dividend yield
- –
Earnings
Quarterly results announced on Form 8-K, Item 2.02
No earnings releases found
Silo Pharma has not filed an earnings release (Form 8-K, Item 2.02) that we could match to a fiscal quarter.
Press releases
Announcements Silo Pharma filed with the SEC
PRICING PRESS RELEASE DATED JULY 10, 2026
Material agreement · Unregistered share sale · Other events · EX-99.1 to Form 8-K
PRESS RELEASE OF SILO PHARMA, INC. DATED JUNE 18, 2026
Other events · EX-99.1 to Form 8-K
PRESS RELEASE OF SILO PHARMA, INC. DATED FEBRUARY 23, 2026
Unregistered share sale · Other events · EX-99.1 to Form 8-K
PRESS RELEASE OF SILO PHARMA, INC. DATED SEPTEMBER 30, 2025
Material agreement · Unregistered share sale · Other events · EX-99.1 to Form 8-K
PRESS RELEASE OF SILO PHARMA, INC. DATED OCTOBER 1, 2025
Material agreement · Unregistered share sale · Other events · EX-99.2 to Form 8-K
PRESS RELEASE DATED AUGUST 5, 2025
Other events · EX-99.1 to Form 8-K
PRICING PRESS RELEASE DATED MAY 15, 2025
Material agreement · Other events · EX-99.1 to Form 8-K
CLOSING PRESS RELEASE DATED MAY 16, 2025
Material agreement · Other events · EX-99.2 to Form 8-K
NOVEL THERAPEUTICS FOR UNMET MEDICAL NEEDS Investor Presentation March 2025
Regulation FD disclosure · Other events · EX-99.1 to Form 8-K
JANUARY 2, 2025 LETTER TO SHAREHOLDERS
Other events · EX-99.1 to Form 8-K
NOVEL THERAPEUTICS FOR UNMET MEDICAL NEEDS Investor Presentation September 2024
Regulation FD disclosure · Other events · EX-99.1 to Form 8-K
PRESS RELEASE OF SILO PHARMA, INC. DATED JULY 19, 2024
Material agreement · Unregistered share sale · Other events · EX-99.1 to Form 8-K
PRESS RELEASE OF SILO PHARMA, INC. DATED JULY 22, 2024
Material agreement · Unregistered share sale · Other events · EX-99.2 to Form 8-K
PRESS RELEASE DATED, JULY 8, 2024
Material agreement · Other events · EX-99.1 to Form 8-K
PRESS RELEASE OF SILO PHARMA, INC. DATED JUNE 5, 2024
Material agreement · Unregistered share sale · Other events · EX-99.1 to Form 8-K
PRESS RELEASE OF SILO PHARMA, INC. DATED JUNE 6, 2024
Material agreement · Unregistered share sale · Other events · EX-99.2 to Form 8-K
PRESS RELEASE DATED JUNE 4, 2024
Other events · EX-99.1 to Form 8-K
PRESS RELEASE DATED FEBRUARY 1, 2024
Other events · EX-99.1 to Form 8-K
FIFTH AMENDMENT TO COMMERCIAL EVALUATION AND LICENSE AGREEMENT, DATED JUNE 28, 2023, BY AND BETWEEN THE COMPANY AND UMB
Other events · EX-99.1 to Form 8-K
PRESS RELEASE DATED MARCH 27, 2023
Other events · EX-99.1 to Form 8-K
PRESS RELEASE DATED FEBRUARY 13, 2023
Other events · EX-99.1 to Form 8-K
PRESS RELEASE DATED FEBRUARY 2, 2023
Other events · EX-99.1 to Form 8-K
PRESS RELEASE DATED JANUARY 30, 2023
Other events · EX-99.1 to Form 8-K
PRESS RELEASE DATED DECEMBER 1, 2022
Other events · EX-99.1 to Form 8-K
Corporate Presentation Nasdaq: SILO 1 Fall 2022
Material agreement · Executive or director change · Regulation FD disclosure · Other events · EX-99.1 to Form 8-K
PRESS RELEASE DATED OCTOBER 18, 2022
Material agreement · Executive or director change · Regulation FD disclosure · Other events · EX-99.2 to Form 8-K
PRESS RELEASE DATED SEPTEMBER 27, 2022
Material agreement · Executive or director change · Other events · EX-99.1 to Form 8-K
PRESS RELEASE DATED SEPTEMBER 29, 2022
Material agreement · Executive or director change · Other events · EX-99.2 to Form 8-K
PRESS RELEASE DATED SEPTEMBER 15, 2022
Charter or bylaw amendment · Other events · EX-99.1 to Form 8-K